A case of ustekinumab treatment in autoimmune enteropathy
10.3760/cma.j.cn101480-20240605-00068
- VernacularTitle:乌司奴单克隆抗体治疗自身免疫性肠病一例
- Author:
Zetian ZHOU
1
;
Yanfang CHEN
;
Xinyi YANG
;
Mingyue LI
;
Hong CHEN
Author Information
1. 东南大学医学院临床医学系,南京 210009
- Publication Type:Journal Article
- Keywords:
Autoimmune enteropathy;
Ustekinumab;
Diarrhea
- From:
Chinese Journal of Inflammatory Bowel Diseases
2025;09(3):259-260
- CountryChina
- Language:Chinese
-
Abstract:
Autoimmune enteropathy (AIE) is an autoimmune disease with unclear pathophysiological mechanisms. It was more commonly observed in children but is increasingly diagnosed in adults. AIE is primarily characterized by chronic diarrhea, malabsorption and villous atrophy in the small intestine. Diagnosis is primarily based on pathological findings. Most patients respond well to corticosteroid therapy. This report presents a patient of AIE with diarrhea as the main symptom. After developing steroid dependence, the patient was switched to ustekinumab and achieved satisfactory therapeutic outcomes.